Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |